Novavax | NVAX - 现金及等价物

金融业

USD

USD 1.04B

现金及等价物

USD 228.36M

USD 22.1M

USD 850.82M

USD 342.46M

USD 233.31M

USD 20.94M

USD 19.36M

1.54K

EPS每股收益

USD 0.13

股本和储备

USD -144.76M

USD 125.04M

债务利息支出

USD 5.82M

USD 303K

USD 246.3M

USD 1.33B

USD 17.53M

USD 126.2M

USD 20.94M

普通股股本

USD 162.58M

2.01

USD 17.9M

USD 147.14M

销售和管理费用

USD 25.53M

USD 11.46M

贸易债权人

USD 16.1M

应收帐款人

USD 106.45M

	现金及等价物	更改		日
Adma Biologics	USD 138.15M		50.52M	2026-03
Agenus	USD 35M		32M	2026-03
AstraZeneca	USD 7.56B		1.85B	2026-03
BioCryst Pharmaceuticals	USD 171.59M		164.32M	2026-03
Cassava Sciences	USD 86.57M		8.93M	2026-03
Geron	USD 68.9M		10.54M	2026-03
GlaxoSmithKline	GBP 3.44B		292M	2026-03
MannKind	USD 52.83M		22.05M	2026-03
Merck	USD 5.33B		9.24B	2026-03
Minerva Neurosciences	USD 82.3M		70.02M	2025-12
Moderna	USD 1.91B		687M	2026-03
Novartis	USD 6.88B		2.68B	2026-03
Novavax	USD 228.36M		12.27M	2026-03
Pfizer	USD 1.7B		561M	2026-03
Sanofi	EUR 7.66B		1.25B	2025-12
Sarepta Therapeutics	USD 464.45M		336.83M	2026-03
TG Therapeutics	USD 442.21M		242.7M	2026-03